These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. van Galen KP, Engelen ET, Mauser-Bunschoten EP, van Es RJ, Schutgens RE. Cochrane Database Syst Rev; 2015 Dec 24; (12):CD011385. PubMed ID: 26704192 [Abstract] [Full Text] [Related]
3. The use of continuous infusion of factor concentrates in the treatment of hemophilia. Bona RD, Weinstein RA, Weisman SJ, Bartolomeo A, Rickles FR. Am J Hematol; 1989 Sep 24; 32(1):8-13. PubMed ID: 2502914 [Abstract] [Full Text] [Related]
11. Role of enhanced half-life factor VIII and IX in the treatment of haemophilia. Mahdi AJ, Obaji SG, Collins PW. Br J Haematol; 2015 Jun 24; 169(6):768-76. PubMed ID: 25754016 [Abstract] [Full Text] [Related]
12. Comprehensive care for hemophilia and other inherited bleeding disorders. Page D. Transfus Apher Sci; 2019 Oct 24; 58(5):565-568. PubMed ID: 31427262 [Abstract] [Full Text] [Related]
13. Treatment protocol of haemophilia and other congenital bleeding disorders in Italy. Italian Association of Hemophilia Centers (AICE). Gringeri A. Haemophilia; 1998 Jul 24; 4(4):423-4. PubMed ID: 9873767 [No Abstract] [Full Text] [Related]
14. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada. CMAJ; 1995 Jul 15; 153(2):147-57. PubMed ID: 7600466 [Abstract] [Full Text] [Related]
17. Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients. Négrier C, Shapiro A, Berntorp E, Pabinger I, Tarantino M, Retzios A, Schroth P, Ewenstein B. Thromb Haemost; 2008 Aug 15; 100(2):217-23. PubMed ID: 18690340 [Abstract] [Full Text] [Related]